A 12-month, single-masked, randomized controlled study of eyes with persistent diabetic macular edema after multiple anti-vegf injections to assess the efficacy of the dexamethasone-delayed delivery system as an adjunct to bevacizumab compared with continued bevacizumab monotherapy.
Phase of Trial: Phase II
Latest Information Update: 17 Feb 2016
At a glance
- Drugs Bevacizumab (Primary) ; Dexamethasone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 17 Feb 2016 New trial record